238 related articles for article (PubMed ID: 18782026)
1. Cytokines in colitis associated cancer: potential drug targets?
Waldner MJ; Neurath MF
Inflamm Allergy Drug Targets; 2008 Sep; 7(3):187-94. PubMed ID: 18782026
[TBL] [Abstract][Full Text] [Related]
2. Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development.
Waldner MJ; Neurath MF
Semin Immunol; 2014 Feb; 26(1):75-9. PubMed ID: 24447345
[TBL] [Abstract][Full Text] [Related]
3. Epithelial Nuclear Factor-x03BA;B Activation in Inflammatory Bowel Diseases and Colitis-Associated Carcinogenesis.
Nagaishi T; Watabe T; Jose N; Tokai A; Fujii T; Matsuoka K; Nagahori M; Ohtsuka K; Watanabe M
Digestion; 2016; 93(1):40-6. PubMed ID: 26789263
[TBL] [Abstract][Full Text] [Related]
4. Analysis of colon-infiltrating γδ T cells in chronic inflammatory bowel disease and in colitis-associated cancer.
Lo Presti E; Mocciaro F; Mitri RD; Corsale AM; Di Simone M; Vieni S; Scibetta N; Unti E; Dieli F; Meraviglia S
J Leukoc Biol; 2020 Aug; 108(2):749-760. PubMed ID: 32202356
[TBL] [Abstract][Full Text] [Related]
5. KFL2 participates in the development of ulcerative colitis through inhibiting inflammation via regulating cytokines.
Wang ZL; Wang YD; Wang K; Li JA; Li L
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4941-4948. PubMed ID: 30070340
[TBL] [Abstract][Full Text] [Related]
6. Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses.
Kontaki E; Boumpas DT; Tzardi M; Mouzas IA; Papadakis KA; Verginis P
Autoimmunity; 2017 May; 50(3):170-181. PubMed ID: 28276713
[TBL] [Abstract][Full Text] [Related]
7. A Decade of Th9 Cells: Role of Th9 Cells in Inflammatory Bowel Disease.
Vyas SP; Goswami R
Front Immunol; 2018; 9():1139. PubMed ID: 29881387
[TBL] [Abstract][Full Text] [Related]
8. Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation.
Autenrieth IB; Bucheler N; Bohn E; Heinze G; Horak I
Gut; 1997 Dec; 41(6):793-800. PubMed ID: 9462212
[TBL] [Abstract][Full Text] [Related]
9. Epithelial Smad4 Deletion Up-Regulates Inflammation and Promotes Inflammation-Associated Cancer.
Means AL; Freeman TJ; Zhu J; Woodbury LG; Marincola-Smith P; Wu C; Meyer AR; Weaver CJ; Padmanabhan C; An H; Zi J; Wessinger BC; Chaturvedi R; Brown TD; Deane NG; Coffey RJ; Wilson KT; Smith JJ; Sawyers CL; Goldenring JR; Novitskiy SV; Washington MK; Shi C; Beauchamp RD
Cell Mol Gastroenterol Hepatol; 2018; 6(3):257-276. PubMed ID: 30109253
[TBL] [Abstract][Full Text] [Related]
10. Potential avenues for immunotherapy of colitis-associated neoplasia.
Waldner MJ; Neurath MF
Immunotherapy; 2012 Apr; 4(4):397-405. PubMed ID: 22512634
[TBL] [Abstract][Full Text] [Related]
11. The oncoprotein gankyrin promotes the development of colitis-associated cancer through activation of STAT3.
Sakurai T; Higashitsuji H; Kashida H; Watanabe T; Komeda Y; Nagai T; Hagiwara S; Kitano M; Nishida N; Abe T; Kiyonari H; Itoh K; Fujita J; Kudo M
Oncotarget; 2017 Apr; 8(15):24762-24776. PubMed ID: 28160571
[TBL] [Abstract][Full Text] [Related]
12. Immunoregulatory Pathways Involved in Inflammatory Bowel Disease.
Fonseca-Camarillo G; Yamamoto-Furusho JK
Inflamm Bowel Dis; 2015 Sep; 21(9):2188-93. PubMed ID: 26111210
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation.
Kullberg MC; Rothfuchs AG; Jankovic D; Caspar P; Wynn TA; Gorelick PL; Cheever AW; Sher A
Infect Immun; 2001 Jul; 69(7):4232-41. PubMed ID: 11401959
[TBL] [Abstract][Full Text] [Related]
14. Immunopathogenesis of Colitis-Associated Cancer in an Animal Model.
Zhao JL; Xiao CX; Guleng B
Crit Rev Eukaryot Gene Expr; 2015; 25(3):245-51. PubMed ID: 26558947
[TBL] [Abstract][Full Text] [Related]
15. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
16. Inflammation and colorectal cancer.
Kraus S; Arber N
Curr Opin Pharmacol; 2009 Aug; 9(4):405-10. PubMed ID: 19589728
[TBL] [Abstract][Full Text] [Related]
17. The impact of mangiferin from Belamcanda chinensis on experimental colitis in rats.
Szandruk M; Merwid-Ląd A; Szeląg A
Inflammopharmacology; 2018 Apr; 26(2):571-581. PubMed ID: 28337639
[TBL] [Abstract][Full Text] [Related]
18. Role of Inflammation in the Development of Colorectal Cancer.
Muthusami S; Ramachandran IK; Babu KN; Krishnamoorthy S; Guruswamy A; Queimado L; Chaudhuri G; Ramachandran I
Endocr Metab Immune Disord Drug Targets; 2021; 21(1):77-90. PubMed ID: 32901590
[TBL] [Abstract][Full Text] [Related]
19. Cytokines: from gut inflammation to colorectal cancer.
Fantini MC; Pallone F
Curr Drug Targets; 2008 May; 9(5):375-80. PubMed ID: 18473765
[TBL] [Abstract][Full Text] [Related]
20. IL-7 promotes long-term in vitro survival of unique long-lived memory subset generated from mucosal effector memory CD4+ T cells in chronic colitis mice.
Takahara M; Nemoto Y; Oshima S; Matsuzawa Y; Kanai T; Okamoto R; Tsuchiya K; Nakamura T; Yamamoto K; Watanabe M
Immunol Lett; 2013; 156(1-2):82-93. PubMed ID: 24070768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]